• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定出具有 N294S 和 S246N 神经氨酸酶替换的印度尼西亚 2.1 分支高致病性 H5N1 流感病毒,这进一步降低了奥司他韦的敏感性。

Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.

机构信息

CSIRO Manufacturing, 343 Royal Parade, Parkville, 3052 Australia.

CSIRO Australian Animal Health Laboratory, Geelong, Australia.

出版信息

Antiviral Res. 2018 May;153:95-100. doi: 10.1016/j.antiviral.2018.03.007. Epub 2018 Mar 21.

DOI:10.1016/j.antiviral.2018.03.007
PMID:29574145
Abstract

We have tested the in vitro susceptibility to the neuraminidase (NA) inhibitors of 96 highly pathogenic clade 2.1 A(H5N1) viruses from Indonesia, isolated between 2008 and 2011. HPAI virus samples obtained through the Influenza Virus Monitoring (IVM) surveillance program in Indonesia were tested for susceptibility to oseltamivir and zanamivir. The NAs of four viruses were identified as extreme outliers to oseltamivir, based on statistical analysis by box plots, with IC values ranging from 46 to 62 nM. The NAs of two of these viruses from Sumatra and Aceh, had an N294S substitution, while one virus from Sulawesi had an S246N NA substitution. The NAs of all four viruses showed a specific loss of slow binding to oseltamivir in an IC kinetics assay. As observed in our previous surveillance, there was only a minimal effect on the sensitivity to zanamivir or peramivir for these mutants or any of the other isolates tested. The continued circulation of subtype H5N1 viruses in avian species poses an on-going zoonotic threat. The fact that we continue to identify avian isolates with naturally occurring mutations conferring reduced oseltamivir susceptibility remains a concern, given oseltamivir will be a key antiviral in the event of a new pandemic emerging.

摘要

我们测试了 96 株来自印度尼西亚的高致病性 2.1 分支 A(H5N1)病毒对神经氨酸酶(NA)抑制剂的体外敏感性,这些病毒株均于 2008 年至 2011 年分离得到。印度尼西亚通过流感病毒监测(IVM)监测计划获得的高致病性禽流感病毒样本,对奥司他韦和扎那米韦的敏感性进行了测试。通过箱线图的统计分析,发现 4 株病毒的 NA 对奥司他韦的敏感性明显异常,IC 值范围为 46 至 62nM。其中两株来自苏门答腊和亚齐的病毒具有 N294S 取代,而来自苏拉威西的一株病毒具有 S246N NA 取代。这 4 株病毒的 NA 均表现出在 IC 动力学测定中对奥司他韦的缓慢结合特异性丧失。正如我们之前的监测所观察到的,这些突变体或测试的其他任何分离株对扎那米韦或帕拉米韦的敏感性仅有微小影响。H5N1 亚型病毒在禽类中的持续传播构成了持续的人畜共患病威胁。鉴于奥司他韦将成为新出现的大流行的关键抗病毒药物,我们继续发现具有自然发生的降低奥司他韦敏感性的突变的禽源分离株仍然令人担忧。

相似文献

1
Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.鉴定出具有 N294S 和 S246N 神经氨酸酶替换的印度尼西亚 2.1 分支高致病性 H5N1 流感病毒,这进一步降低了奥司他韦的敏感性。
Antiviral Res. 2018 May;153:95-100. doi: 10.1016/j.antiviral.2018.03.007. Epub 2018 Mar 21.
2
I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses.I222 神经氨酸酶突变进一步降低了印度尼西亚 2.1 分支高致病性禽流感 A(H5N1)病毒对奥司他韦的敏感性。
PLoS One. 2013 Jun 11;8(6):e66105. doi: 10.1371/journal.pone.0066105. Print 2013.
3
A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir.神经氨酸酶中 I117T 取代导致高致病性禽流感 H5N1 病毒对奥司他韦和扎那米韦的敏感性降低。
Vet Microbiol. 2019 Aug;235:21-24. doi: 10.1016/j.vetmic.2019.06.005. Epub 2019 Jun 5.
4
Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015).印度从禽类中分离出的高致病性 H5N1 流感病毒对神经氨酸酶抑制剂的敏感性特征。(2006-2015 年)
Antiviral Res. 2018 Oct;158:143-146. doi: 10.1016/j.antiviral.2018.08.007. Epub 2018 Aug 17.
5
Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors.新兴甲型流感病毒对神经氨酸酶和帽子依赖性内切酶抑制剂的基因型和表型敏感性。
Antiviral Res. 2024 Sep;229:105959. doi: 10.1016/j.antiviral.2024.105959. Epub 2024 Jul 8.
6
Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.2002-2012 年全球分离的高致病性流感 A(H5N1)病毒的抗病毒耐药性表明需要持续监测。
Antiviral Res. 2013 May;98(2):297-304. doi: 10.1016/j.antiviral.2013.02.013. Epub 2013 Feb 28.
7
Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.对可能对多种神经氨酸酶抑制剂具有耐药性的流感病毒 N1 株进行分析和鉴定。
J Virol. 2015 Jan;89(1):287-99. doi: 10.1128/JVI.02485-14. Epub 2014 Oct 15.
8
Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.2009-2011 年越南从家禽中分离的高致病性禽流感 A(H5N1)病毒的抗病毒敏感性。
Emerg Infect Dis. 2013 Dec;19(12):1963-71. doi: 10.3201/eid1912.130705.
9
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.高致病性A(H5N1)禽流感病毒对神经氨酸酶抑制剂和金刚烷类药物的敏感性。
Antiviral Res. 2007 Mar;73(3):228-31. doi: 10.1016/j.antiviral.2006.10.004. Epub 2006 Nov 10.
10
Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.位置 294 的天冬酰胺到丝氨酸突变对高致病性 H5N1 流感 A 病毒致病性的影响。
J Virol. 2011 May;85(10):4667-72. doi: 10.1128/JVI.00047-11. Epub 2011 Mar 2.

引用本文的文献

1
Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.2020 - 2023年流感病毒对神经氨酸酶抑制剂和帽依赖性核酸内切酶抑制剂巴洛沙韦敏感性的全球最新情况
Antiviral Res. 2025 Sep;241:106217. doi: 10.1016/j.antiviral.2025.106217. Epub 2025 Jun 24.
2
Antiviral Susceptibility of Influenza A(H5N1) Clade 2.3.2.1c and 2.3.4.4b Viruses from Humans, 2023-2024.2023 - 2024年来自人类的甲型流感病毒(H5N1)2.3.2.1c和2.3.4.4b分支的抗病毒敏感性
Emerg Infect Dis. 2025 Apr;31(4):751-760. doi: 10.3201/eid3104.241820. Epub 2024 Mar 10.
3
Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses.
流感 A 型和 B 型病毒中研究性神经氨酸酶抑制剂 AV5080 的耐药谱。
Antiviral Res. 2023 Sep;217:105701. doi: 10.1016/j.antiviral.2023.105701. Epub 2023 Aug 9.
4
Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022.2022 年美国从鸟类和哺乳动物中分离出的 2.3.4.4b 分支高致病性禽流感 A(H5N1)病毒的抗病毒敏感性。
Antiviral Res. 2023 Sep;217:105679. doi: 10.1016/j.antiviral.2023.105679. Epub 2023 Jul 24.
5
Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview.甲型流感病毒的人畜共患病潜力:全面概述。
Viruses. 2018 Sep 13;10(9):497. doi: 10.3390/v10090497.